Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sala

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Physical Review Letters|July 31, 2025
Stability and Loop Models from Decohering Non-Abelian Topological OrderPablo Sala, Ruben Verresen
Oncology (Williston Park, N.Y.)|February 16, 2018
Counterpoint: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer. Neoadjuvant Therapy Should Not Be Used as Part of Standard Clinical PracticePablo Sala Elarre, Kenneth H Yu
Physical Review Letters|November 4, 2022
Dynamics in Systems with Modulated SymmetriesPablo Sala, Julius Lehmann, Tibor Rakovszky, et al.
Physical Review Letters|April 11, 2026
Intrinsic Heralding and Optimal Decoders for Non-Abelian Topological OrderDian Jing, Pablo Sala, Liang Jiang, et al.
Physical Review Letters|January 7, 2021
Anomalous Diffusion in Dipole- and Higher-Moment-Conserving SystemsJohannes Feldmeier, Pablo Sala, Giuseppe De Tomasi, et al.
Nature Communications|July 24, 2021
Observing non-ergodicity due to kinetic constraints in tilted Fermi-Hubbard chainsSebastian Scherg, Thomas Kohlert, Pablo Sala, et al.
Physical Review Letters|January 20, 2023
Exploring the Regime of Fragmentation in Strongly Tilted Fermi-Hubbard ChainsThomas Kohlert, Sebastian Scherg, Pablo Sala, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 11, 2023
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinomaAnna Vilalta-Lacarra, Azucena Aldaz, Pablo Sala-Elarre, et al.
Cancers|July 28, 2019
Omics Approaches in Pancreatic AdenocarcinomaIranzu González-Borja, Antonio Viúdez, Saioa Goñi, et al.
Biomedicines|February 25, 2023
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic StrategiesLuis Mejías Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Physical Review Letters|July 31, 2025
Stability and Loop Models from Decohering Non-Abelian Topological OrderPablo Sala, Ruben Verresen
Oncology (Williston Park, N.Y.)|February 16, 2018
Counterpoint: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer. Neoadjuvant Therapy Should Not Be Used as Part of Standard Clinical PracticePablo Sala Elarre, Kenneth H Yu
Physical Review Letters|November 4, 2022
Dynamics in Systems with Modulated SymmetriesPablo Sala, Julius Lehmann, Tibor Rakovszky, et al.
Physical Review Letters|April 11, 2026
Intrinsic Heralding and Optimal Decoders for Non-Abelian Topological OrderDian Jing, Pablo Sala, Liang Jiang, et al.
Physical Review Letters|January 7, 2021
Anomalous Diffusion in Dipole- and Higher-Moment-Conserving SystemsJohannes Feldmeier, Pablo Sala, Giuseppe De Tomasi, et al.
Nature Communications|July 24, 2021
Observing non-ergodicity due to kinetic constraints in tilted Fermi-Hubbard chainsSebastian Scherg, Thomas Kohlert, Pablo Sala, et al.
Physical Review Letters|January 20, 2023
Exploring the Regime of Fragmentation in Strongly Tilted Fermi-Hubbard ChainsThomas Kohlert, Sebastian Scherg, Pablo Sala, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 11, 2023
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinomaAnna Vilalta-Lacarra, Azucena Aldaz, Pablo Sala-Elarre, et al.
Cancers|July 28, 2019
Omics Approaches in Pancreatic AdenocarcinomaIranzu González-Borja, Antonio Viúdez, Saioa Goñi, et al.
Biomedicines|February 25, 2023
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic StrategiesLuis Mejías Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, et al.
Pageof 2